Page (1) of 1 - 01/12/18
Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer
January 12, 2018 --
This article is no longer available,but here are some related topics.
Inc.,Medicine,medical technologists,Cancer,Surgery,Medication,Womens Health,Science,Lifestyle,Medical,Biology,Stem Cell,Cancer,Business,Science,
All Rights Reserved